SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001387131-22-007077
Filing Date
2022-06-17
Accepted
2022-06-17 16:33:46
Documents
10
Period of Report
2022-07-29

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROXY STATEMENT admp-pre14a_072922.htm PRE 14A 1058163
2 GRAPHIC admppre001.jpg GRAPHIC 4045
3 GRAPHIC admppre002.jpg GRAPHIC 579
4 GRAPHIC admppre003.jpg GRAPHIC 600
5 GRAPHIC admppre004.jpg GRAPHIC 580
6 GRAPHIC admppre005.jpg GRAPHIC 4335
7 GRAPHIC admppre006.jpg GRAPHIC 4418
8 GRAPHIC admppre007.jpg GRAPHIC 3879
9 GRAPHIC admppre008.jpg GRAPHIC 4838
10 GRAPHIC admppre010.jpg GRAPHIC 7057
  Complete submission text file 0001387131-22-007077.txt   1102258
Mailing Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36242 | Film No.: 221024390
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences